Skip to main content
    C

    Corbus Pharmaceuticals Holding (CRBP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.01
    -0.36 (-10.81%)

    Market Cap: $69.86M

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Corbus Pharmaceuticals Holding (CRBP) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Corbus Pharmaceuticals Holding (CRBP) has a latest price of $3.01 on Nov 17, 2026, 76.6% below its 52-week high of $12.88. Its price fell 72.8% over the past 12 months. The month-end price fell 97.5% over the 10 years through Oct 2026, a compound annual decline of 30.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $278.83 in Aug 2020 and its lowest $2.99 in Feb 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CRBP with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRBP.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 69.9%, and over 6 months it fell 67.1%. The month-end price fell 22.6% over the 3 years through Oct 2026, a compound annual decline of 8.2%.

    PeriodChange
    1 month-32.5%
    3 months-69.9%
    6 months-67.1%
    12 months-72.8%
    12 months, with dividends-72.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-22.6%-8.2%
    5 years-85.9%-32.5%
    10 years-97.5%-30.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 95.4%, and its weakest was 2022, when it fell 82.1%.

    YearCloseChange
    2026 through Oct 2026$4.22-48.2%
    2025$8.14-31.0%
    2024$11.80+95.4%
    2023$6.04+82.0%
    2022$3.32-82.1%
    2021$18.49-50.7%
    2020$37.54-77.1%
    2019$163.96-6.5%
    2018$175.38-17.7%
    2017$213.21-16.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 43.9% below its 50-day average of $5.36 and 63.8% below its 200-day average of $8.31.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.01
    52-week high$12.88-76.6%
    52-week low$2.81+7.1%
    50-day average$5.36-43.9%
    200-day average$8.31-63.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.4%.

    MeasureValue
    1-year beta1.83
    Largest fall, 1 year-76.5%
    Largest fall, 3 years-95.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CRBP

    What is CRBP's 1-year price change?

    Corbus Pharmaceuticals Holding's price fell 72.8% over the past 12 months. With dividends included, the 12-month total return was -72.8%.

    What is CRBP's 5-year price change?

    Corbus Pharmaceuticals Holding's month-end price fell 85.9% over the 5 years through Oct 2026, a compound annual decline of 32.5%. These figures leave out dividends.

    What is CRBP's 52-week high and low?

    Corbus Pharmaceuticals Holding's 52-week high is $12.88 and its 52-week low is $2.81. Its latest price of $3.01 on Nov 17, 2026 is 76.6% below the high.

    What is CRBP's beta?

    Corbus Pharmaceuticals Holding's 1-year beta against the S&P 500 is 1.83, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 76.5%.

    Is the CRBP chart free?

    Yes. Advanced Charting for CRBP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.